Publications

Found 14 results
Filters: Keyword is Mice and Author is Benoît Stijlemans  [Clear All Filters]
2014
La Greca, F., C. Haynes, B. Stijlemans, C. De Trez, and S. Magez, "Antibody-mediated control of Trypanosoma vivax infection fails in the absence of tumour necrosis factor.", Parasite Immunol, vol. 36, issue 6, pp. 271-6, 2014 Jun.
2011
Stijlemans, B., G. Caljon, S. Kumar A. Natesan, D. Saerens, K. Conrath, D. Pérez-Morga, J. N. Skepper, A. Nikolaou, L. Brys, E. Pays, et al., "High affinity nanobodies against the Trypanosome brucei VSG are potent trypanolytic agents that block endocytosis.", PLoS Pathog, vol. 7, issue 6, pp. e1002072, 2011 Jun.
2010
Stijlemans, B., A. Vankrunkelsven, L. Brys, G. Raes, S. Magez, and P. De Baetselier, "Scrutinizing the mechanisms underlying the induction of anemia of inflammation through GPI-mediated modulation of macrophage activation in a model of African trypanosomiasis.", Microbes Infect, vol. 12, issue 5, pp. 389-99, 2010 May.
2008
Saerens, D., B. Stijlemans, T. Nath Baral, G. Thanh Nguy Thi, U. Wernery, S. Magez, P. De Baetselier, S. Muyldermans, and K. Conrath, "Parallel selection of multiple anti-infectome Nanobodies without access to purified antigens.", J Immunol Methods, vol. 329, issue 1-2, pp. 138-50, 2008 Jan 1.
Stijlemans, B., A. Vankrunkelsven, L. Brys, S. Magez, and P. De Baetselier, "Role of iron homeostasis in trypanosomiasis-associated anemia.", Immunobiology, vol. 213, issue 9-10, pp. 823-35, 2008.
2007
Stijlemans, B., T. Nath Baral, M. Guilliams, L. Brys, J. Korf, M. Drennan, J. Van Den Abbeele, P. De Baetselier, and S. Magez, "A glycosylphosphatidylinositol-based treatment alleviates trypanosomiasis-associated immunopathology.", J Immunol, vol. 179, issue 6, pp. 4003-14, 2007 Sep 15.
2006
Baral, T. Nath, S. Magez, B. Stijlemans, K. Conrath, B. Vanhollebeke, E. Pays, S. Muyldermans, and P. De Baetselier, "Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor.", Nat Med, vol. 12, issue 5, pp. 580-4, 2006 May.
Caljon, G., J. Van Den Abbeele, B. Stijlemans, M. Coosemans, P. De Baetselier, and S. Magez, "Tsetse fly saliva accelerates the onset of Trypanosoma brucei infection in a mouse model associated with a reduced host inflammatory response.", Infect Immun, vol. 74, issue 11, pp. 6324-30, 2006 Nov.
2005
Drennan, M. B., B. Stijlemans, J. Van Den Abbeele, V. J. Quesniaux, M. Barkhuizen, F. Brombacher, P. De Baetselier, B. Ryffel, and S. Magez, "The induction of a type 1 immune response following a Trypanosoma brucei infection is MyD88 dependent.", J Immunol, vol. 175, issue 4, pp. 2501-9, 2005 Aug 15.
2004
Magez, S., C. Truyens, M. Merimi, M. Radwanska, B. Stijlemans, P. Brouckaert, F. Brombacher, E. Pays, and P. De Baetselier, "P75 tumor necrosis factor-receptor shedding occurs as a protective host response during African trypanosomiasis.", J Infect Dis, vol. 189, issue 3, pp. 527-39, 2004 Feb 1.
2002
Magez, S., B. Stijlemans, G. Caljon, H-P. Eugster, and P. De Baetselier, "Control of experimental Trypanosoma brucei infections occurs independently of lymphotoxin-alpha induction.", Infect Immun, vol. 70, issue 3, pp. 1342-51, 2002 Mar.
2001
Magez, S., M. Radwanska, B. Stijlemans, H. V. Xong, E. Pays, and P. De Baetselier, "A conserved flagellar pocket exposed high mannose moiety is used by African trypanosomes as a host cytokine binding molecule.", J Biol Chem, vol. 276, issue 36, pp. 33458-64, 2001 Sep 7.
2000
Radwanska, M., S. Magez, A. Michel, B. Stijlemans, M. Geuskens, and E. Pays, "Comparative analysis of antibody responses against HSP60, invariant surface glycoprotein 70, and variant surface glycoprotein reveals a complex antigen-specific pattern of immunoglobulin isotype switching during infection by Trypanosoma brucei.", Infect Immun, vol. 68, issue 2, pp. 848-60, 2000 Feb.
1998
Magez, S., B. Stijlemans, M. Radwanska, E. Pays, M. A. Ferguson, and P. De Baetselier, "The glycosyl-inositol-phosphate and dimyristoylglycerol moieties of the glycosylphosphatidylinositol anchor of the trypanosome variant-specific surface glycoprotein are distinct macrophage-activating factors.", J Immunol, vol. 160, issue 4, pp. 1949-56, 1998 Feb 15.